{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458270465
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = NCA-90 (granulocyte antigen)
<!-- Clinical data -->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 250242-54-7
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Lemalesomab''' is a [[mouse]] [[monoclonal antibody]] for the diagnosis of inflammatory [[lesion]]s.<ref>[http://whqlibdoc.who.int/druginfo/DRUG_INFO_14_4_2000_INN-84.pdf WHO Drug Information]</ref>

==References==
{{reflist}}

{{Monoclonals for immune system}}

[[Category:Monoclonal antibodies]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}